Anavex Life Sciences (AVXL) Interest Coverage Ratio (2016 - 2025)
Anavex Life Sciences (AVXL) posted Interest Coverage Ratio of 0.0 for Q4 2025, down 713.44% sequentially from 0.0 in Q3 2025, and up 98.87% YoY from 0.0 in Q4 2024.
Anavex Life Sciences (AVXL) Interest Coverage Ratio (2016 - 2025) Analysis & Trends
Anavex Life Sciences has reported Interest Coverage Ratio for 10 years, with the latest figure at 0.0 in Q4 2025.
- Quarterly Interest Coverage Ratio rose 98.87% year-over-year to 0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.02 (up 97.86% YoY) and the FY2025 annual result came in at 0.0, up 99.77% from the prior year.
- Interest Coverage Ratio eased to 0.0 in Q4 2025 per AVXL's latest filing, from 0.0 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.95 in Q2 2021 and troughed at 1.95 in Q2 2024.
- A 5-year average of 0.18 and a median of 0.23 in 2023 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2021 and 2024: Interest Coverage Ratio soared 255.06% in 2021, then plunged 464.32% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 0.09 in 2021, then tumbled by 241.81% to 0.3 in 2022, then rose by 21.38% to 0.24 in 2023, then grew by 17.59% to 0.2 in 2024, then jumped by 98.87% to 0.0 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.0, 0.0, and 0.32 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Anavex Life Sciences | 298.40 Mn | 166.65 Mn | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -0.32 |
| Mar 31, 2025 | -0.32 |
| Dec 31, 2024 | -0.20 |
| Sep 30, 2024 | -0.15 |
| Jun 30, 2024 | -1.95 |
| Mar 31, 2024 | -1.01 |
| Dec 31, 2023 | -0.24 |
| Sep 30, 2023 | -0.57 |
| Jun 30, 2023 | -0.35 |
| Mar 31, 2023 | -0.32 |
| Dec 31, 2022 | -0.30 |
| Sep 30, 2022 | -0.25 |
| Jun 30, 2022 | -0.21 |
| Mar 31, 2022 | -0.14 |
| Dec 31, 2021 | -0.09 |
| Sep 30, 2021 | 0.92 |
| Jun 30, 2021 | 0.95 |
| Mar 31, 2021 | 0.93 |